The Winners and Losers of 340B Changes
The Winners and Losers of 340B ChangesWhat CMS' big changes to the 340B Drug Discount Program will mean.
CMS plan to slash 340B payments under fire by hospitalsHere are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.
Five pharmacy regulations health execs must keep on their radars in 2017Here are five critical regulations that executives can begin to prepare for today.
New 340B drug rule sets drugmaker finesConsumer health groups are praising Health and Human Services’ (HHS) new rule on the Medicaid 340B drug discount program, which sets a ceiling on drug prices.
Helping Small Organizations Meet the 340B ChallengeMany smaller organizations rely on the 340B program to continue serving their communities – and they can’t afford penalties for noncompliance.
Four reasons why a hospital should open an integrated pharmacyWhen is retail right? Consider these four benefits that will impact the bottom line.
Explore three pathways to fast-growing pharmacy nicheThere are more ways than one to run a specialty pharmacy — and success can be found with any of them.
Five top trends for health-system pharmacies in 2016Value is not just about controlling costs; it also means increasing revenues. Health systems expect it, and pharmacy departments deliver.
Top 10 Managed Healthcare Executive articles of 2015What Managed Healthcare Executive content was most popular this year? Find out here.
Judge rules: Orphan drugs not subject to 340B discountsJudge Rudolph Contreras ruled against the Department of Health and Human Services by saying that pharma companies do not have to offer rural and cancer hospitals that serve low-income populations 340B discounts on orphan drugs.